# Sciegen Pharmaceuticals Inc – FDA Inspection, Feb 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/c0bb89dd-507e-46db-a766-fad3d39acd40
Source feed: FDA_Inspections

> FDA inspection 1229682 of Sciegen Pharmaceuticals Inc, February 20, 2024. Classification: No Action Indicated (NAI). 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229682
- Company Name: Sciegen Pharmaceuticals Inc
- Inspection Date: 2024-02-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1317246 - 2026-05-15](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/a00d1c75-1c9e-4b7c-82cc-eda5065cbf25)
- [FDA Inspection 1297968 - 2025-12-19](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/dbc62b1e-da3f-4e51-b99e-d9e5f6698380)
- [FDA Inspection 1204858 - 2023-04-21](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/78debf30-0ef4-42cc-be44-6bb8ef0669d0)
- FDA Inspection 1178870 - 2022-09-02
- FDA Inspection 1159297 - 2021-12-20

## Related Officers

- [Amatul H. Marium](https://www.keypedia.com/people/amatul-h-marium/5db400ce-ffde-4310-82f8-766fd2458a4d)

Company: https://www.keypedia.com/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
